Results 71 to 80 of about 7,748 (181)

Prevalence and Clinical Impacts of Canine Herpesvirus‐1 (CHV‐1) in Dogs: A Review of Reproductive Effects and Ocular Lesions

Veterinary Medicine and Science, Volume 11, Issue 6, November 2025.
Taxonomy: Herpesviridae, Alphaherpesvirinae and Varicellovirus. Diagnosis: PCR for genetic detection. Transmission: Birth, venereal and transplacental. Pathogenesis: Ocular lesions; blepharitis, conjunctivitis and ulcerative and non‐ulcerative keratitis.
Sina Soleimani, Mohammadreza Ghorani, Amir Mohammad Naghshe Javaheri, Mahdiye Shirafkan, Hadi Bakhtiari   +4 more
wiley   +1 more source

Prospects for Improving Quality Evaluation of the Live Brucellosis Vaccine in Terms of Specific Activity

Биопрепараты: Профилактика, диагностика, лечение, 2020
Prophylactic immunisation against brucellosis is part of the National Immunisation Schedule for Epidemic Settings. The immunisation is performed with a live vaccine—a lyophilized suspension of the Brucella abortus strain 19 BА in a stabilizing medium ...
I. V. Kasina, S. A. Alekseeva, T. I. Nemirovskaya   +2 more
doaj   +1 more source

In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate [PDF]

Iranian Journal of Basic Medical Sciences, 2014
Objective(s):Brucellosis, especially caused by Brucella melitensis, remains one of the most common zoonotic diseases worldwide with more than 500,000 human cases reported annually.
Amir Ghasemi, Reza Ranjbar, Jafar Amani
doaj  

FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella

Vaccines
Background: Brucellosis poses a significant public health challenge, necessitating effective vaccine development. Current vaccines have limitations such as safety concerns and inadequate mucosal immunity.
Tingting Tian, Yuejie Zhu, Kaiyu Shang, Huidong Shi, Ruixue Xu, Mingzhe Li, Fuling Pu, Junyu Kuang, Jianbing Ding, Fengbo Zhang   +9 more
doaj   +1 more source

In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD

Scientific Reports
Brucella, a gram-negative intracellular bacterium, causing Brucellosis, a zoonotic disease with a range of clinical manifestations, from asymptomatic to fever, fatigue, loss of appetite, joint and muscle pain, and back pain, severe patients have ...
Juan Shi, Yuejie Zhu, Zhengwei Yin, Yueyue He, Yujiao Li, Gulishati Haimiti, Xinru Xie, Ce Niu, Wenhong Guo, Fengbo Zhang   +9 more
doaj   +1 more source

Production of specific brucellin to diagnose Brucellosis

مجلة بغداد للعلوم, 2013
act : A soluble cytoplasmic antigen (Brucellin) was prepared from Brucella melitensis Rev1 and used to diagnose brucellosis in experimentally infected mice with virulent strains of Brucella melitensis and Brucella abortus two weeks after infection.
Baghdad Science Journal
doaj   +1 more source

Evaluation and Differential Diagnosis of a Genetic Marked Brucella Vaccine A19ΔvirB12 for Cattle. [PDF]

Front Immunol, 2021
Yang J, He C, Zhang H, Liu M, Zhao H, Ren L, Wu D, Du F, Liu B, Han X, He S, Chen Z.   +11 more
europepmc   +1 more source

Outbreak of occupational Brucella infection caused by live attenuated Brucella vaccine in a biological products company in Chongqing, China, 2020. [PDF]

Emerg Microbes Infect, 2022
Zhou C, Huang W, Xiang X, Qiu J, Xiao D, Yao N, Shu Q, Zhou S.   +7 more
europepmc   +1 more source

Innocuity and immune response to Brucella melitensis Rev.1 vaccine in camels (Camelus dromedarius) [PDF]

Open Veterinary Journal, 2014
A field trial was conducted in a camel brucellosis-free herd to evaluate antibody response to the Brucella melitensis Rev.1 vaccine in camels and assess shedding of the vaccine strain in milk. Twenty eight camels were divided into four groups according
A. Benkirane, A.H. El Idrissi, A. Doumbia, K. de Balogh   +3 more
doaj  

Immunogenicity of glycine nanoparticles containing a chimeric antigen as Brucella vaccine candidate. [PDF]

Clin Exp Vaccine Res, 2021
Karevan G, Ahmadi K, Taheri RA, Fasihi-Ramandi M.   +3 more
europepmc   +1 more source